Molecular characterization of feline interleukin 16: Chemotactic activity and effect on feline immunodeficiency virus infection and/or replication

AIDS Research and Human Retroviruses

Volumn 16, Issue 6, 2000, Pages 569-575

  Leutenegger, Christian M ^a,c   huder, Jon B ^a   Mislin, Caroline N ^a   Lahrtz, Fritz ^b   Hofmann Lehmann, Regina ^a   Pedersen, Niels C ^c   Lutz, Hans ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 16;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CAT; CAT DISEASE; CHEMOTAXIS; FELINE IMMUNODEFICIENCY VIRUS; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; CATS; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CLONING, MOLECULAR; ESCHERICHIA COLI; IMMUNODEFICIENCY VIRUS, FELINE; INTERLEUKIN-16; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRUS REPLICATION;

EID: 0034630301     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200308981     Document Type: Article

References (30)

1. Cruikshank WW, Center DM, Nisar N, Wu M, Natke B, Theodore AC, and Kornfeld H: Molecular and functional analysis of a lymphocyte chemoattractant factor: Association of biologic function with CD4 expression. Proc Natl Acad Sci USA 1994;91:5109-5113.
2. + T-cells is independent of transcription and translation. Evidence for constitutive protein synthesis and storage. J Immunol 1995;155:2902-2910.
3. + T-cells in vitro. J Immunol 1996;156:310-315.
4. Cruikshank WW, Lim K, Theodore AC, Cook J, Fine G, Weller PF, and Center DM: IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J Immunol 1996;157:5240-5248.
5. + T-cells by IL-16 and IL-2. J Immunol 1998;160:2115-2120.
6. Baier M, Werner A, Bannert N, Metzner K, and Kurth R: HIV suppression by interleukin-16. Nature 1995;378:563.
7. Amiel C, Darcissac E, Truong MJ, Dewulf J, Loyens M, Mouton Y, Capron A, and Bahr GM: Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression. J Infect Dis 1999;179:83-91.
8. Bisset LR, Rothen M, Joller-Jemelka HI, Dubs RW, Grob PJ, and Opravil M: Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 1 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir. AIDS 1997;11:485-491.
9. Boyden S: The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med 1962;115:453.
10. Leutenegger CM, Hofmann-Lehmann R, Holznagel E, Cuisinier AM, Wolfensberger C, Duquesne V, Cronier J, Allenspach K, Aubert A, Ossent P, and Lutz H: Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins. AIDS Res Hum Retroviruses 1998;14:275-283.
11. Muhlhahn P, Zweckstetter M, Georgescu J, Ciosto C, Renner C, Lanzendorfer M, Lang K, Ambrosius D, Baier M, Kurth R, et al.: Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site. Nature Struct Biol 1998;5:682-686.
12. Keane J, Nicoll J, Kim S, Wu DM, Cruikshank WW, Brazer W, Natke B, Zhang Y, Center DM, and Kornfeld H: Conservation of structure and function between human and murine IL-16. J Immunol 1998;160:5945-5954.
13. Baier M, Bannert N, Werner A, Lang K, and Kurth R: Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci USA 1997;94:5273-5277.
14. Zhang Y, Center DM, Wu DM, Cruikshank WW, Yuan J, Andrews DW, and Kornfeld H: Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem 1998;273:1144-1149.
15. Nicoll J, Cruikshank WW, Brazer W, Liu Y, Center DM, and Kornfeld H: Identification of domains in IL-16 critical for biological activity. J Immunol 1999;163:1827-1832.
16. Theodore AC, Center DM, Nicoll J, Fine G, Kornfeld H, and Cruikshank WW: CD4 ligand IL-16 inhibits the mixed lymphocyte reaction. J Immunol 1996;157:1958-1964.
17. Liu Y, Cruikshank WW, O'Loughlin T, O'Reilly P, Center CM, and Kornfeld H: Identification of a CD4 domain required for interleukin-16 binding and lymphocyte activation. J Biol Chem 1999;274:23387-23395.
18. Satoh T, Li S, Friedman TM, Wiaderkiewicz R, Korngold R, and Huang Z: Synthetic peptides derived from the fourth domain of CD4 antagonize off function and inhibit T cell activation. Biochem Biophys Res Commun 1996;224:438-443.
19. Leutenegger CM, Huder JB, Hofmann-Lehmann R, and Lutz H: Molecular cloning and expression of feline interleukin-16. DNA Sequence 1998;9:59-63.
20. Lee ME, Adams JW, Villinger F, Brar SS, Meadows M, Bucur SZ, Lackey DA, Brice GT, Cruikshank WW, Ansari AA, and Hillyer CD: Molecular cloning and expression of rhesus macaque and sooty mangabey interleukin 16: Biologic activity and effect on simian immunodeficiency virus infection and/or replication. AIDS Res Hum Retroviruses 1998;14:1323-1328.
21. + T-cells. Science 1995;270:1811-1815.
22. Idziorek T, Khalife J, Billaut-Mulot O, Hermann E, Aumercier M, Mouton Y, Capron A, and Bahr GM: Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD). Clin Exp Immunol 1998;112:84-91.
23. Scala E, D'Offizi G, Rosso R, Turriziani O, Ferrara R, Mazzone AM, Antonelli G, Aiuti F, and Paganelli R: C-C chemokines IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J Immunol 1997;158:4485-4492.
24. Maciaszek JW, Parada NA, Cruikshank WW, Center DM, Kornfeld H, and Viglianti GA: IL-16 represses HIV-1 promoter activity. J Immunol 1997;158:5-8.
25. Truong MJ, Darcissac EC, Hermann E, Dewuld J, Capron A, and Bahr GM: Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells. J Virol 1999;73:7008-7013.
26. Sparger EE, Shacklett BL, Renshaw-Gegg L, Barry PA, Pedersen NC, Elder JH, and Luciw PA: Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology 1992;187:165-177.
27. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563-1566.
28. + T-cells. Immunol Today 1996;17:217-224.
29. + T-cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci USA 1995;92:2308-2312.
30. Mackewicz CE, Levy JA, Cruikshank WW, Kornfeld H, and Center DM: Role of IL-16 in HIV replication. Nature 1996; 383:488-489.